| Authors: |
Tsang ES; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA.; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada., Aggarwal RR; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Bergsland EK; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Calabrese S; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Rozie A; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Chaudhuri S; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Dhawan MS; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Pawlowska N; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Grabowsky J; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Thomas S; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA., Munster PN; Division of Hematology and Oncology, University of California San Francisco, San Francisco, CA. |
